一种新型的维抗凝:制备,鉴定和与血栓激素的相互作用
Yaxin Zhang1, Binfei Lv1, Shan Gao1
1Tianjin Key Laboratory of Food Quality and Health, College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, PR China.
Journal of the science of food and agriculture
|December 12, 2025
概括
研究人员从维中分离出强大的抗凝,维是一种高度酸化的蛋白质. 这些可以抑制血栓激素,并为开发用于血液凝固管理的新功能性食物提供有希望的基础.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自然酸化是一种有前途的抗凝策略.
- 维是一种高度酸化的蛋白质,通过抑制血栓激素,表现出抗凝固特性.
研究的目的:
- 为了优化维丁水解盐的制备,以提高血栓抑制活性.
- 从维中分离和鉴别出对抗凝固作用负责的多化.
主要方法:
- 使用两步酶化水解来制备维水解剂.
- 染色学净化被用来隔离活性分数.
- 进行了类鉴定和血栓结合测试.
主要成果:
- 优化的水解显著增强了胺抑制活性.
- 富含pSSKpSSNpSpSK的P4分离体显示出强烈抑制血栓的作用.
- 的多酸化对于抑制血素和与血素异位I结合至关重要.
- pSSKpSSNpSpSK延长了血凝时间和激活了部分血栓塑时间,表明了广泛的抗凝活性.
结论:
- 来自维的多酸化有效抑制血栓凝结.
- 这些干扰了内源性和常见的凝血通路.
- 这些发现为开发具有抗凝固功能的食品提供了理论基础.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262


